Nawal Hlal Almutairi
Biographic Data
| ID | 8420493 |
|---|---|
| NAME | Nawal Hlal Almutairi |
| GIVEN NAMES | Nawal Hlal |
| FAMILY NAME | Almutairi |
| SIGNATURE | ALMUTAIRI N H |
| AFFILIATIONS | National Guard Health Affairs |
| VERIFIED | No |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 8 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Combination therapies
Background: Tuberculosis (TB) is a significant global health issue requiring prolonged treatment regimens that often involve multiple medications. Mycobacterium tuberculosis, the causative agent, is capable of residing in various tissue compartments during infection, leading to variability in drug accessibility and susceptibility. The complexity of the infection necessitates the use of antibiotic combinations to ensure that all affected areas are…
Pharmaceutical supply chain management
Background: The globalization of pharmaceutical supply chains has exposed significant vulnerabilities, enabling counterfeit medications to infiltrate the market. These counterfeit drugs not only fail to aid in the recovery of patients but also pose serious health risks due to their inferior quality. The World Health Organization (WHO) reports that in developing nations, approximately 10% of medications consumed by patients are counterfeit. This a…
Improving patient care through collaborative practices between nursing, pharmacy, and laboratory services
Background: One of the critical antecedent conditions in any given healthcare institution involves communication between and among various healthcare workers. Nonetheless, the combined teams experience communication challenges that create mistakes, inadequacies, and negatively impact the patient. Aim: The objective of this study is therefore to establish ways on how interdisciplinary healthcare teams especially the nursing, medical, pharmacy and …
Rise of Biosimilars
Background: Biologics have transformed the management of immune-mediated inflammatory conditions, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). The introduction of biosimilars—biologic medications that are highly similar and interchangeable with approved originators—has the potential to enhance market competition and improve patient access to necessary therapies. Aim of Work: This review aims to highlight the importance …
Advancing oncology care
Background: Oncology care has witnessed significant advancements, necessitating a multidisciplinary approach that integrates pharmacological therapies, nursing support, and laboratory diagnostics. Pharmacological innovations such as targeted therapies and immunotherapies have transformed treatment paradigms, while nursing interventions and advanced diagnostics play critical roles in enhancing patient outcomes. Despite these advances, the intersec…
The role of pharmacogenomics in personalized nursing care
Background: Pharmacogenomics (PGx), the study of genetic variations affecting drug response, is a cornerstone of personalized medicine. It holds immense potential in nursing care by enabling tailored treatment strategies, enhancing therapeutic efficacy, and minimizing adverse drug reactions (ADRs). Despite its promise, PGx integration into clinical nursing practice faces challenges such as high costs, limited access to testing, and a knowledge ga…
The impact of biotechnology on pharmaceutical manufacturing
Background _ Bioengineering tools have revolutionized the production of pharmaceutical bioproducts by streamlining processes and reducing the time required for development. These tools are applicable across various biological platforms, including plants, animals, and microorganisms, offering substantial advantages in the pharmaceutical industry. Aim of Work – This review aims to highlight the benefits and advancements in bioengineering tools for …
Integration of clinical pharmacy, nursing, and medical laboratories
Background: Modern healthcare systems increasingly depend on interdisciplinary collaboration to address complex medical needs, enhance patient outcomes, and improve service quality. Effective integration among clinical pharmacy, nursing, and medical laboratories is vital in optimizing treatment accuracy, medication safety, and patient-centered care. However, challenges such as role ambiguity, communication gaps, and resource constraints often lim…
No prominent works on this page.
Integration of clinical pharmacy, nursing, and medical laboratories
Background: Modern healthcare systems increasingly depend on interdisciplinary collaboration to address complex medical needs, enhance patient outcomes, and improve service quality. Effective integration among clinical pharmacy, nursing, and medical laboratories is vital in optimizing treatment accuracy, medication safety, and patient-centered care. However, challenges such as role ambiguity, communication gaps, and resource constraints often lim…
The role of pharmacogenomics in personalized nursing care
Background: Pharmacogenomics (PGx), the study of genetic variations affecting drug response, is a cornerstone of personalized medicine. It holds immense potential in nursing care by enabling tailored treatment strategies, enhancing therapeutic efficacy, and minimizing adverse drug reactions (ADRs). Despite its promise, PGx integration into clinical nursing practice faces challenges such as high costs, limited access to testing, and a knowledge ga…
The impact of biotechnology on pharmaceutical manufacturing
Background _ Bioengineering tools have revolutionized the production of pharmaceutical bioproducts by streamlining processes and reducing the time required for development. These tools are applicable across various biological platforms, including plants, animals, and microorganisms, offering substantial advantages in the pharmaceutical industry. Aim of Work – This review aims to highlight the benefits and advancements in bioengineering tools for …
Advancing oncology care
Background: Oncology care has witnessed significant advancements, necessitating a multidisciplinary approach that integrates pharmacological therapies, nursing support, and laboratory diagnostics. Pharmacological innovations such as targeted therapies and immunotherapies have transformed treatment paradigms, while nursing interventions and advanced diagnostics play critical roles in enhancing patient outcomes. Despite these advances, the intersec…
Improving patient care through collaborative practices between nursing, pharmacy, and laboratory services
Background: One of the critical antecedent conditions in any given healthcare institution involves communication between and among various healthcare workers. Nonetheless, the combined teams experience communication challenges that create mistakes, inadequacies, and negatively impact the patient. Aim: The objective of this study is therefore to establish ways on how interdisciplinary healthcare teams especially the nursing, medical, pharmacy and …
Rise of Biosimilars
Background: Biologics have transformed the management of immune-mediated inflammatory conditions, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). The introduction of biosimilars—biologic medications that are highly similar and interchangeable with approved originators—has the potential to enhance market competition and improve patient access to necessary therapies. Aim of Work: This review aims to highlight the importance …
Pharmaceutical supply chain management
Background: The globalization of pharmaceutical supply chains has exposed significant vulnerabilities, enabling counterfeit medications to infiltrate the market. These counterfeit drugs not only fail to aid in the recovery of patients but also pose serious health risks due to their inferior quality. The World Health Organization (WHO) reports that in developing nations, approximately 10% of medications consumed by patients are counterfeit. This a…
Combination therapies
Background: Tuberculosis (TB) is a significant global health issue requiring prolonged treatment regimens that often involve multiple medications. Mycobacterium tuberculosis, the causative agent, is capable of residing in various tissue compartments during infection, leading to variability in drug accessibility and susceptibility. The complexity of the infection necessitates the use of antibiotic combinations to ensure that all affected areas are…
Medicine (6 works) · Biotechnology and Related Fields (3 works) · Business (3 works) · Nursing (3 works) · Biology (2 works) · Health Sciences Research and Education (2 works) · Innovations in Medical Education (2 works) · Intensive care medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Pharmacy (2 works)